Inspire Medical Systems, Inc. ist eine Aktie aus dem Premium-Bereich von aktien.guide. Bitte anmelden, um einen Alarm für Inspire Medical Systems, Inc. zu aktivieren.
Kostenlos registrieren
Bitte registriere Dich kostenlos, um Inspire Medical Systems, Inc. zu Deinem Portfolio hinzuzufügen.
aktien.guide Unlimited – alle Details der KI-Analysen
Mit Unlimited erhältst du die vollständige KI-Funktionalität für Inspire Medical Systems, Inc.. 👉 Detailliertere Insights 👉 Exklusive Einblicke in Chancen & Risiken 👉 Klare Antworten auf deine Fragen
LOS ANGELES , Dec. 15, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE: INSP). IF YOU SUFFERED A LOSS ON YOUR INSPIRE INVESTMENTS, CLICK HERE BEFORE JANUARY 5, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURI...
NEW YORK , Dec. 15, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), of the important January 5, 2026 lead plaintiff deadline. So what: If you purchased Inspire Medical common stock during the Class Per...
Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline SAN FRANCISCO , Dec. 15, 2025 /PRNewswire/ -- National investor rights law firm Hagens Berman alerts INSP investors to the pending securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP). The firm is urging INSP investors who suffered substantial losses to contact atto...
NEW YORK , Dec. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Inspire Medical Systems, Inc. (NYSE: INSP). Shareholders who purchased shares of INSP during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Our portfolios underperformed during the quarter and trail year to date. Health care was the primary hindrance as a result of our underweight in biotech and negative stock selection. We have materially decreased our position as we evaluate this specific risk.
LOS ANGELES, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Inspire Medical Sytems, Inc. ("Inspire" or the "Company") (NYSE: INSP) securities between August 6, 2024 and August 4, 2025 inclusive (the “Class ...
Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline
Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline SAN FRANCISCO , Dec. 11, 2025 /PRNewswire/ -- National investor rights law firm Hagens Berman alerts INSP investors to the pending securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP). The firm is urging INSP investors who suffered substantial losses to contact atto...
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.